|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/04/18 Cit Group Inc 10-Q 3/31/18 112:25M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 2.13M
2: EX-10.23 Material Contract HTML 170K
3: EX-10.24 Material Contract HTML 111K
4: EX-12.1 Statement re: Computation of Ratios HTML 43K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 38K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 38K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 34K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 34K
15: R1 Document and Entity Information HTML 51K
16: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 128K
17: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 66K
(Parenthetical)
18: R4 Condensed Consolidated Statements of Income HTML 139K
(Unaudited)
19: R5 Condensed Consolidated Statements of Comprehensive HTML 52K
Income (Unaudited)
20: R6 Condensed Consolidated Statements of Stockholders' HTML 67K
Equity (Unaudited)
21: R7 Condensed Consolidated Statements of Cash Flows HTML 138K
(Unaudited)
22: R8 Business and Summary of Significant Accounting HTML 87K
Policies
23: R9 Discontinued Operations HTML 155K
24: R10 Loans HTML 656K
25: R11 Allowance For Loan Losses HTML 119K
26: R12 Investment Securities HTML 275K
27: R13 Borrowings HTML 165K
28: R14 Derivative Financial Instruments HTML 215K
29: R15 Fair Value HTML 475K
30: R16 Stockholders' Equity HTML 161K
31: R17 Regulatory Capital HTML 94K
32: R18 Income Taxes HTML 43K
33: R19 Commitments HTML 91K
34: R20 Contingencies HTML 47K
35: R21 Business Segment Information HTML 139K
36: R22 Subsequent Events HTML 37K
37: R23 Business and Summary of Significant Accounting HTML 104K
Policies (Policies)
38: R24 Business and Summary of Significant Accounting HTML 51K
Policies (Tables)
39: R25 Discontinued Operations (Tables) HTML 154K
40: R26 Loans (Tables) HTML 641K
41: R27 Allowance For Loan Losses (Tables) HTML 119K
42: R28 Investment Securities (Tables) HTML 278K
43: R29 Borrowings (Tables) HTML 155K
44: R30 Derivative Financial Instruments (Tables) HTML 266K
45: R31 Fair Value (Tables) HTML 438K
46: R32 Stockholders' Equity (Tables) HTML 158K
47: R33 Regulatory Capital (Tables) HTML 90K
48: R34 Commitments (Tables) HTML 70K
49: R35 Business Segment Information (Tables) HTML 140K
50: R36 Business and Summary of Significant Accounting HTML 54K
Policies (Narrative) (Details)
51: R37 Discontinued Operations (Schedule of Condensed HTML 61K
Balance Sheet Aerospace Discontinued Operations)
(Details)
52: R38 Discontinued Operations (Schedule of Condensed HTML 82K
Statements of Income and Cash Flow of Aerospace
Discontinued Operations) (Details)
53: R39 Discontinued Operations (Narrative) (Details) HTML 53K
54: R40 Discontinued Operations (Schedule of Condensed HTML 81K
Balance Sheet Financial Freedom Discontinued
Operations) (Details)
55: R41 Discontinued Operations (Schedule of Condensed HTML 77K
Statements of Income and Cash Flow of Financial
Freedom Discontinued Operations) (Details)
56: R42 Discontinued Operations (Schedule of Condensed HTML 63K
Combined Balance Sheet of Discontinued Operations)
(Details)
57: R43 Discontinued Operations (Schedule of Condensed HTML 73K
Combined Statements of Income and Cash Flow of
Discontinued Operations) (Details)
58: R44 Loans (Schedule of Loans by Product) (Details) HTML 49K
59: R45 Loans (Schedule of Loans by Segment, Based on HTML 50K
Obligor Location) (Details)
60: R46 Loans (Components of Net Investment in Loans) HTML 39K
(Details)
61: R47 Loans (Commercial Loans and Held-For-Sale Loans - HTML 127K
By Risk Rating) (Details)
62: R48 Loans (Narrative) (Details) HTML 105K
63: R49 Loans (Schedule of Consumer Loan LTV HTML 86K
Distributions) (Details)
64: R50 Loans (Loans and Held For Sale Loans - Delinquency HTML 120K
Status) (Details)
65: R51 Loans (Loans on Non-accrual Status) (Details) HTML 84K
66: R52 Loans (Schedule of Loans In Process of Foreclosure HTML 44K
and OREO) (Details)
67: R53 Loans (Impaired Loans) (Details) HTML 86K
68: R54 Loans (Purchased Credit Impaired Loans) (Details) HTML 59K
69: R55 Loans (Summary of Commercial PCI Loans by Credit HTML 50K
Quality) (Details)
70: R56 Loans (Schedule of Changes to the Accretable Yield HTML 45K
for PCI Loans) (Details)
71: R57 Allowance For Loan Losses (Schedule of Allowance HTML 102K
for Loan Losses and Recorded Investment in Finance
Receivables) (Details)
72: R58 Investment Securities (Schedule of Investment HTML 61K
Securities) (Details)
73: R59 Investment Securities (Narrative) (Details) HTML 69K
74: R60 Investment Securities (Schedule of Interest and HTML 43K
Dividend Income) (Details)
75: R61 Investment Securities (Amortized Cost and Fair HTML 72K
Value of AFS and HTM Securities) (Details)
76: R62 Investment Securities (Schedule of Amortized Cost HTML 104K
and Fair Value Maturities with Changes Recorded in
Net Income) (Details)
77: R63 Investment Securities (Schedule of AFS and HTM - HTML 74K
Estimated Unrealized Losses) (Details)
78: R64 Investment Securities (Changes in Accretable Yield HTML 51K
for Purchased Credit-Impaired Securities)
(Details)
79: R65 Borrowings (Schedule of Long-Term Borrowings) HTML 56K
(Details)
80: R66 Borrowings (Narrative) (Details) HTML 149K
81: R67 Borrowings (Schedule of Senior Unsecured Notes) HTML 56K
(Details)
82: R68 Borrowings (Schedule of FHLB Advances with Pledged HTML 38K
Assets) (Details)
83: R69 Borrowings (Schedule of Structured Financings and HTML 55K
Pledged Assets) (Details)
84: R70 Borrowings (Assets and Liabilities in HTML 56K
Unconsolidated VIEs) (Details)
85: R71 Derivative Financial Instruments (Fair and HTML 81K
Notional Values of Derivative Financial
Instruments) (Details)
86: R72 Derivative Financial Instruments (Offsetting of HTML 80K
Derivative Assets and Liabilities) (Details)
87: R73 Derivative Financial Instruments (Narrative) HTML 58K
(Details)
88: R74 Derivative Financial Instruments Derivative HTML 41K
Financial Instruments (Fair Value Hedges)
(Details)
89: R75 Derivative Financial Instruments (Derivative HTML 55K
Instrument Gains and Losses) (Details)
90: R76 Derivative Financial Instruments (Changes in AOCI HTML 48K
Relating to Derivatives) (Details)
91: R77 Fair Value (Assets and Liabilities Measured at HTML 85K
Fair Value on a Recurring Basis) (Details)
92: R78 Fair Value (Narrative) (Details) HTML 103K
93: R79 Fair Value (Quantitative Information about Level 3 HTML 88K
Fair Value Measurements-Recurring) (Details)
94: R80 Fair Value (Changes in Estimated Fair Value for HTML 81K
Financial Assets and Liabilities Measured on
Recurring Basis) (Details)
95: R81 Fair Value (Carrying Value of Assets Measured at HTML 69K
Fair Value on a Non-Recurring Basis) (Details)
96: R82 Fair Value (Carrying and Estimated Fair Values of HTML 139K
Financial Instruments) (Details)
97: R83 Stockholder's Equity (Schedule of Common Stock HTML 56K
Activity) (Details)
98: R84 Stockholders' Equity (Narrative) (Details) HTML 63K
99: R85 Stockholders' Equity (Components of Accumulated HTML 49K
Other Comprehensive Income (Loss) ("Aoci"))
(Details)
100: R86 Stockholders' Equity (Changes in Accumulated Other HTML 65K
Comprehensive Income (Loss) by Component)
(Details)
101: R87 Stockholders' Equity (Reclassifications out of HTML 57K
AOCI) (Details)
102: R88 Regulatory Capital (Tier 1 Capital and Total HTML 78K
Capital Components) (Details)
103: R89 Income Taxes (Narrative) (Details) HTML 58K
104: R90 Commitments (Summary of Commitments) (Details) HTML 73K
105: R91 Commitments (Narrative) (Details) HTML 79K
106: R92 Contingencies (Narrative) (Details) HTML 41K
107: R93 Business Segment Information (Segment Pre-Tax HTML 111K
Income (Loss)) (Details)
108: R94 Subsequent Events (Details) HTML 65K
109: R9999 Uncategorized Items - cit-20180331.xml HTML 35K
111: XML IDEA XML File -- Filing Summary XML 216K
110: EXCEL IDEA Workbook of Financial Reports XLSX 175K
9: EX-101.INS XBRL Instance -- cit-20180331 XML 8.82M
11: EX-101.CAL XBRL Calculations -- cit-20180331_cal XML 350K
12: EX-101.DEF XBRL Definitions -- cit-20180331_def XML 1.78M
13: EX-101.LAB XBRL Labels -- cit-20180331_lab XML 2.82M
14: EX-101.PRE XBRL Presentations -- cit-20180331_pre XML 2.11M
10: EX-101.SCH XBRL Schema -- cit-20180331 XSD 292K
112: ZIP XBRL Zipped Folder -- 0001628280-18-005979-xbrl Zip 563K
| Exhibit |
CIT Group Inc. and Subsidiaries Computation of Ratio of Earnings to Fixed Charges (dollars in millions) | |||||||||||
Quarters
Ended | |||||||||||
Earnings: | |||||||||||
Net income | $ | 97.0 | $ | (88.0 | ) | $ | 179.9 | ||||
Provision
(benefit) for income taxes - continuing operations | 41.3 | 27.7 | 56.2 | ||||||||
(Income) loss from discontinued operations, net of taxes | 6.7 | 5.2 | (101.7 | ) | |||||||
Income
from continuing operations, before provision (benefit) or income taxes | 145.0 | (55.1 | ) | 134.4 | |||||||
Fixed Charges: | |||||||||||
Interest
and debt expenses on indebtedness | 180.5 | 168.7 | 163.1 | ||||||||
Interest factor: one-third of rentals on real and personal properties | 3.8 | 3.9 | 3.6 | ||||||||
Total
fixed charges for computation of ratio | 184.3 | 172.6 | 166.7 | ||||||||
Total earnings before provision (benefit) for income taxes and fixed charges | $ | 329.3 | $ | 117.5 | $ | 301.1 | |||||
Ratios
of earnings to fixed charges | 1.79x | 0.68x | 1.81x | ||||||||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/4/18 | |||
| For Period end: | 3/31/18 | |||
| 12/31/17 | 10-K | |||
| 3/31/17 | 10-Q, 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/05/21 Cit Group Inc. 10-Q 9/30/21 110:47M ActiveDisclosure/FA 7/30/21 Cit Group Inc. 10-Q 6/30/21 111:47M ActiveDisclosure/FA 4/30/21 Cit Group Inc. 10-Q 3/31/21 111:42M ActiveDisclosure/FA 4/30/21 Cit Group Inc. 10-K/A 12/31/20 14:1.6M Donnelley … Solutions/FA 2/19/21 Cit Group Inc. 10-K 12/31/20 214:68M ActiveDisclosure/FA 10/30/20 Cit Group Inc. 10-Q 9/30/20 146:52M ActiveDisclosure/FA |